October 2017

Process and Impact Evaluation of the National Cancer Diagnostics Capacity Fund

SQW has been appointed by NHS England to undertake the process and impact evaluation of the National Cancer Diagnostics Capacity Fund. The study will run until May 2018, and will identify best practice for increasing diagnostic capacity, generating lessons which can be used throughout the wider NHS.

The Fund was one of the recommendations from the independent Cancer Taskforce Report, Achieving World-Class Cancer Outcomes, and improving cancer waiting times is a key objective for NHS England. The Diagnostics Capacity Fund's key aims are to:

  • Improve performance against the 62-day cancer waiting time standard
  • Improve patient experience
  • Reduce variation in 62-day cancer waiting time performance compared to the national average.

The Fund allocated non-recurrent funding to 30 projects for delivery in 2016/7. Initiatives include a focus on:

  • Networking diagnostic services between providers
  • Resequencing or redesigning diagnostic pathways
  • Using the workforce differently.

SQW's study will involve a programme-wide review of the activities and outcomes emerging, as well as an in-depth focus on six case study projects. We will be conducting site visits, consultations, an in-depth document review, and analysis of secondary data at project and programme levels.

For further information about the study, please contact Lauren Roberts at SQW. For further information about the National Cancer Diagnostics Capacity Fund, please contact Eva Caley, NHS England Project Manager (eva.caley@nhs.net).